Davis Cammann
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
-
- Alzheimer's disease research and treatments
- Diet and metabolism studies
Papers in
-
- Alzheimer's disease research and treatments 4
-
- Prion Diseases and Protein Misfolding 1
- Co-authors
- Jeffrey L. Cummings (4 shared papers)Jingchun Chen (6 shared papers)Amanda M. Leisgang Osse (2 shared papers)Yimei Lu (2 shared papers)Edwin C. Oh (1 shared paper)Xiangning Chen (1 shared paper)Jeffrey L. Ebersole (1 shared paper)Jefferson W. Kinney (1 shared paper)
- Journals
- Nature Communications (2 papers)CNS Drugs (1 paper)BioDrugs (1 paper)Journal of Translational Medicine (1 paper)Frontiers in Neuroscience (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Davis Cammann
7 papers receiving 356 citations
Davis Cammann's Hit Papers
Peers
Comparison fields: 5 of 78
- Biological Psychiatry 44
- Physiology 159
- Neurology 44
- Psychiatry and Mental health 37
- Pharmacology 41
Countries citing papers authored by Davis Cammann
This map shows the geographic impact of Davis Cammann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davis Cammann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davis Cammann more than expected).
Fields of papers citing papers by Davis Cammann
This network shows the impact of papers produced by Davis Cammann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davis Cammann. The network helps show where Davis Cammann may publish in the future.
Co-authors
The 25 scholars most cited alongside Davis Cammann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease Hit paper breakdown → | 2023 | 194 |
| 2 | Genetic correlations between Alzheimer’s disease and gut microbiome genera Hit paper breakdown → | 2023 | 110 |
| 3 | 2024 | 29 | |
| 4 | 2025 | 17 | |
| 5 | 2025 | 5 | |
| 6 | 2024 | 3 | |
| 7 | 2025 | 2 |
About Davis Cammann
Davis Cammann is a scholar working on Physiology, Molecular Biology, Genetics, Infectious Diseases and Pharmacology, having authored 7 papers that have together received 360 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Genetic Associations and Epidemiology (2 papers), Computational Drug Discovery Methods (1 paper), Clostridium difficile and Clostridium perfringens research (1 paper), Tryptophan and brain disorders (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper), Prion Diseases and Protein Misfolding (1 paper) and Dementia and Cognitive Impairment Research (1 paper). The work is most often cited by research in Biological Psychiatry (44 citations), Physiology (159 citations), Neurology (44 citations), Psychiatry and Mental health (37 citations) and Pharmacology (41 citations). Davis Cammann has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Jeffrey L. Cummings, Jingchun Chen, Amanda M. Leisgang Osse, Yimei Lu, Edwin C. Oh, Xiangning Chen, Jeffrey L. Ebersole, Jefferson W. Kinney, Yadi Zhou and Alexandra Stone. Their work appears in journals such as Nature Communications, CNS Drugs, BioDrugs, Journal of Translational Medicine and Frontiers in Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.